Early Life
Herriot Tabuteau was born in Haiti and immigrated to the United States at the age of nine. He grew up in Manhattan's Upper East Side, surrounded by medical institutions like Rockefeller University and Memorial Sloan Kettering Cancer Center. This environment fostered his early interest in science. He attended Xavier High School and graduated from Wesleyan University with a degree in molecular biology and biochemistry.
Rise to Success
Tabuteau's career began in healthcare finance, where he gained experience at Goldman Sachs and later as a partner at the healthcare hedge fund Healthco/S.A.C. Capital. In 2012, he founded Axsome Therapeutics, with a focus on developing treatments for central nervous system disorders. Axsome went public in 2015. His work led to the development and commercialization of Auvelity, a groundbreaking antidepressant, and other drugs for Alzheimer's disease.
Key Business Strategies
Tabuteau's strategy involved focusing on brain disorders, often neglected by the pharmaceutical industry. He built a portfolio approach, and ran clinical trials in-house to reduce costs. He also made smart acquisitions, such as Sunosi in 2022.
Philanthropy
Specific philanthropy amounts could not be found, but Tabuteau's work focuses on improving the lives of those affected by neurological and psychiatric disorders.